Clinical Trials Directory

Trials / Completed

CompletedNCT05087693

Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)

Examining the Effect of Salbutamol Use in Asthma and/or Exercise Induced Bronchoconstriction Whilst Exercising in Ozone Air Pollution

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
18 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Salbutamol use is increased in areas with high levels of ozone pollution and the potential consequences of this are not well known. The purpose of this study is to examine the effect of salbutamol on lung function and inflammation in people with asthma and/or EIB exercising in ozone air pollution. To examine this, we are planning a randomized cross over trial where people with asthma and/or EIB complete sub maximal exercise in four conditions on four separate days. The four condition are: ozone + salbutamol, filtered air + salbutamol, ozone + placebo medication, and filtered air + placebo medication.

Conditions

Interventions

TypeNameDescription
DRUGSalbutamolInhaling 200ug of salbutamol
DRUGPlacebo medicationInhaling placebo medication
OTHEROzoneBreathing 170ppb ozone
OTHERFiltered AirBreathing filtered air
OTHERExerciseCycling at 60% of VO2max on a cycle ergometer

Timeline

Start date
2021-11-01
Primary completion
2023-08-31
Completion
2023-08-31
First posted
2021-10-21
Last updated
2025-03-14
Results posted
2025-03-14

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05087693. Inclusion in this directory is not an endorsement.